Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and pulmonary hypertension were found.

Additional research is needed to determine whether this is due to direct drug effects or underlying patient factors.

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital (SIUH) in Ocean Breeze has been recognized with the highest ...

Connie Bowling, a 75-year-old deaf patient from Forsyth County, received a left ventricular assist device (LVAD) in March ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...

The decision to move forward with a heart transplant is made when all other treatment options been unsuccessful.

Local healthcare centre, connected to a bigger hospital through the chat platform, can administer clot-dissolving drugs ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

MACRO trial researchers said adapting to the COVID-19 pandemic mid-trial may have undercut the efficacy of the intervention, ...

Background: The American Indian population in the United States experiences marked cardiovascular health disparities.

When pregnant patients and their families receive a prenatal diagnosis of a congenital heart defect (CHD), it sparks ...